지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Background: Hyperosmolar therapy is an essential treatment method for increased intracranial pressure and cerebral edema. Mannitol and hypertonic saline are frequently used in clinical practice; however, more helpful recommendations are needed for the optimal management of cerebral edema in terms of the choice, dosage, and timing of these medications. This study aimed to introduce the characteristics and relative strengths of two agents, i.e., mannitol and hypertonic saline, and review clinical data supporting their use in various diseases.
Current Concepts: Hyperosmolar therapy reduces intracranial pressure by removing water from the brain tissue and transferring it to the vascular space by creating an osmotic gradient. Mannitol improves cerebral blood flow by reducing the hematocrit, decreasing blood viscosity, and increasing deformability of red blood cells.
Hypertonic saline increases intravascular volume, transiently increases cardiac output, and improves tissue oxygen partial pressure in the brain. Hypertonic saline has several advantages over mannitol, including quicker onset and longer-lasting reduction in intracranial pressure. However, no significant differences are noted in clinical, functional outcomes, or mortality between the two treatment agents.
Discussion and Conclusion: Both mannitol and hypertonic saline are effective in reducing increased intracranial pressure. Clinicians should be able to select an appropriate agent in different clinical situations based on available evidence and patients’ individual medical conditions.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
뇌부종의 고삼투압 치료에서 부작용 관리
대한의사협회지
2023 .05
-
Role of continuous hypertonic saline in acute ischemic infarcts: a systematic literature review
Journal of Neurocritical Care
2021 .01
-
Critical Care Management and Monitoring of Intracranial Pressure
Journal of Neurocritical Care
2016 .01
-
뇌부종과 두개내압 상승의 기본치료원칙
대한의사협회지
2023 .05
-
Optimal treatment with hypertonic saline in patients with symptomatic hyponatremia: a perspective from a randomized clinical trial (SALSA trial)
Kidney Research and Clinical Practice
2020 .01
-
뇌부종과 두개내압 조절을 위한 뇌관류압 최적화 치료
대한의사협회지
2023 .05
-
Optimizing Mannitol Use in Managing Increased Intracranial Pressure: A Comprehensive Review of Recent Research and Clinical Experiences
Korean Journal of Neurotrauma
2023 .06
-
Pediatric post-concussion bradypnea and hypopnea treated with hypertonic saline: a case report
대한소아응급의학회지
2024 .04
-
The Monitoring of Brain Edema and Intracranial Hypertension
Journal of Neurocritical Care
2016 .01
-
뇌부종에서 목표체온유지치료
대한의사협회지
2023 .05
-
두개수술 후 뇌압상승 대상자 집중간호
한국의료시뮬레이션학회지
2023 .06
-
Unexpected Severe Cerebral Edema after Cranioplasty : Case Report and Literature Review
대한신경외과학회지
2015 .01
-
Intracranial Atherosclerosis: Where Are We Now?
대한뇌졸중학회지
2017 .01
-
Hypertonic dextrose spray as topical endoscopic hemostasis for non-variceal upper gastrointestinal bleeding
International Journal of Gastrointestinal Intervention
2023 .04
-
뇌부종이 있는 뇌경색 환자들에서 만니톨과 신부전의 연관성
Journal of Neurocritical Care
2016 .01
-
Negative pressure pulmonary edema
Korean Journal of Anesthesiology
2018 .01
-
Intracranial Stenting; the Current Landscape
Neurointervention
2021 .01
-
Negative-pressure helmet restores cerebral hemodynamic parameters in sinking skin flap syndrome: a case report
Journal of Neurocritical Care
2022 .12
이 논문의 저자 정보
최근 본 자료
댓글(0)
0